Table 1_Association of brain-derived neurotrophic factor levels at different trimesters and new-onset depressive symptom in the third trimester among pregnant women: a longitudinal... by Yue-rong Zhang (21838784)

“…Each 1 pg/mL increase of first trimester BDNF was associated with a 43% decrease in the risk of prenatal depressive symptoms (95% confidence interval [95% CI]: 0.51, 0.65); each 1 pg/mL increase of second trimester BDNF was a 39% decrease in the risk of prenatal depressive symptoms (95% CI: 0.54, 0.68); each 1 pg/mL increase of third trimester BDNF was associated with a 36% decrease in the risk of prenatal depressive symptoms (95% CI: 0.58, 0.71).…”

Linear regressions of pPOM and sPOM stable carbon and nitrogen isotope values versus collection date. by Nathan D. McTigue (10706460)

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Effect of anti-<i>Leishmania</i> compounds on fecundity of females and egg fertility. by Tainá Neves Ferreira (21601579)

Impact of group 1 and group 2 drugs on hyperglycemia based on HbA1c levels before and after 3 months of administration. by Nadia Gul (249538)

Correlations between perceptual bias scores, age, and autism-associated features: Simple linear regression showing a significant correlation between elevated proprioceptive bias an... by Daniel E. Lidstone (21567523)

Measurement of the mortality rate of RPW third and fifth instar larvae after three and six days of exposure to three different dsRNAs. by Muhammad Naeem Sattar (19828497)

Setup on a greenhouse table for the four densities tested in the density trial, exemplary for replicate 1. by Torsten Schober (20485754)

Turtle orientation data analysis: Circular plot with fitted WEED pdf and rose diagram (left), linear histogram with fitted pdf (center), and empirical CDF with fitted CDF (right). by Sakhr A. S. Alotaibi (22216601)

Linear fit parameters of OQ_EGG and OQ_GAW. by Jonas Kirsch (20642910)

Change^a in incidence of repetition according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Change^a in incidence of dropout according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Middle cerebral artery mean flow velocity at three time points. by Marco Carbonara (11483575)

Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”